BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37751987)

  • 1. Clinical effects of tranexamic acid on bleeding tendency due to fibrinolytic activation of AL amyloidosis.
    Matsumoto G; Mori H; Mori T; Sakaki C
    BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37751987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation and fibrinolytic features in AL amyloidosis with abnormal bleeding and usefulness of tranexamic acid.
    Arahata M; Takamatsu H; Morishita E; Kadohira Y; Yamada S; Ichinose A; Asakura H
    Int J Hematol; 2020 Apr; 111(4):550-558. PubMed ID: 31897889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein.
    Ishiguro K; Hayashi T; Yokoyama Y; Aoki Y; Onodera K; Ikeda H; Ishida T; Nakase H
    Intern Med; 2018 Mar; 57(6):783-788. PubMed ID: 29021469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma.
    Takahashi H; Koike T; Yoshida N; Kitahara O; Hanano M; Shibata A; Aoki N
    Am J Hematol; 1986 Oct; 23(2):153-66. PubMed ID: 2944378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report.
    Ono E; Ishii A; Higashi Y; Koita N; Ayaki T; Tanigaki K; Takayanagi S; Kondo N; Sakai K; Endo S; Yokoi H; Matsubara T; Minamiguchi S; Nishino I; Takahashi R; Yanagita M
    BMC Nephrol; 2021 Feb; 22(1):74. PubMed ID: 33639890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of bleeding upper aerodigestive tract tumor-a novel approach with antifibrinolytic agent: case series and literature review.
    Low TH; Huang J; Reid C; Elliott M; Clark JR
    Laryngoscope; 2013 Oct; 123(10):2449-52. PubMed ID: 23553514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effective treatment with tranexamic acid for chronic disseminated intravascular coagulation associated with aortic dissection].
    Tsuji T; Morikawa K; Hirano T; Yamasaki H; Tsuda H
    Rinsho Ketsueki; 2013 Aug; 54(8):769-71. PubMed ID: 24005438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid for patients with nasal haemorrhage (epistaxis).
    Joseph J; Martinez-Devesa P; Bellorini J; Burton MJ
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD004328. PubMed ID: 30596479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment of ulinastatin and tranexamic acid provides beneficial effects by inhibiting inflammatory and fibrinolytic response in patients undergoing heart valve replacement surgery.
    Chen TT; Jiandong-Liu ; Wang G; Jiang SL; Li LB; Gao CQ
    Heart Surg Forum; 2013 Feb; 16(1):E38-47. PubMed ID: 23439357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloidosis presenting as lower gastrointestinal hemorrhage.
    Spier BJ; Einstein M; Johnson EA; Zuricik AO; Hu JL; Pfau PR
    WMJ; 2008 Feb; 107(1):40-3. PubMed ID: 18416369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; McClelland B; Laupacis A; Fergusson D
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001886. PubMed ID: 17943760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis.
    McCormack PL
    Drugs; 2012 Mar; 72(5):585-617. PubMed ID: 22397329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding Control in Palliative Care Patients With the Help of Tranexamic Acid.
    Geist MJP; Kessler J; Frankenhauser S; Bardenheuer HJ
    J Palliat Care; 2017 Apr; 32(2):47-48. PubMed ID: 28920517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular manifestation of giant cell arteritis vs AL-amyloidosis: similar presentations but different approaches.
    Azarfar A; Sharma A; Parikh JG; Shaikh NM; King-Morris K
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):117-122. PubMed ID: 32787554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT.
    Roberts I; Shakur-Still H; Afolabi A; Akere A; Arribas M; Austin E; Bal K; Bazeer N; Beaumont D; Brenner A; Carrington L; Chaudhri R; Coats T; Gilmore I; Halligan K; Hussain I; Jairath V; Javaid K; Kayani A; Lisman T; Mansukhani R; Miners A; Mutti M; Nadeem MA; Pollok R; Prowse D; Simmons J; Stanworth S; Veitch A; Williams J
    Health Technol Assess; 2021 Oct; 25(58):1-86. PubMed ID: 34663491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic Acid to Treat Life-threatening Hemorrhage in Prostate Cancer Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis.
    Prokopchuk-Gauk O; Brose K
    Cureus; 2015 Dec; 7(12):e428. PubMed ID: 26848417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid.
    Dockeray CJ; Sheppard BL; Daly L; Bonnar J
    Eur J Obstet Gynecol Reprod Biol; 1987 Apr; 24(4):309-18. PubMed ID: 2953634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.